LMR Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
LMR Partners's ABBV Position: Q3 2026 in Review
LMR Partners reduced its AbbVie (ABBV) stake by 13% in Q3 2026, selling an estimated $2.64M and leaving 69,445 shares worth $18.2M. The position accounts for 0.06% of the portfolio, ranked #279.
LMR Partners first reported a position in ABBV in Q3 2014 and has held it in 30 quarters since. The position peaked at $20.1M in Q2 2026. 4,280 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- LMR Partners held 69,445 shares of AbbVie worth $18.2M as of Q3 2026.
- LMR Partners sold 10,291 AbbVie shares in Q3 2026, an estimated $2.64M.
- AbbVie made up 0.06% of LMR Partners's portfolio in Q3 2026, its #279 holding.
- LMR Partners first reported a position in AbbVie in Q3 2014 and has held it in 30 quarters since.
- LMR Partners's AbbVie position peaked at $20.1M in Q2 2026.
- 4,280 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.